Amgen Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slid 1.27% to $283.40 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.59% to 4,027.26 and the Dow Jones Industrial Average rising 0.28% to 34,194.06. This was the stock's second consecutive day of losses. Amgen Inc. closed $13.27 short of its 52-week high ($296.67), which the company reached on November 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.11% to $177.01, Roche Holding AG Part. Cert. rose 1.89% to $323.42, and Pfizer Inc. (PFE) fell 0.47% to $48.85. Trading volume (2.9 M) eclipsed its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 23, 2022.
(END) Dow Jones Newswires
November 23, 2022 16:36 ET (21:36 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.